EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSUAMG00000022343
Gene Symbol: ITGB6
2 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSUAMG00000003137
Gene Symbol: ITGB7
2 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSUAMG00000001425
Gene Symbol: ITGB8
2 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSUAMG00000026675
Gene Symbol: IRAK4
2 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSUAMG00000015517
Gene Symbol: IL5
2 Cross references
91 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSUAMG00000023788
Gene Symbol: IL6
2 Cross references
162 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSUAMG00000009431
Gene Symbol: IDH1
2 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSUAMG00000007835
Gene Symbol: IDH2
2 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSUAMG00000015377
Gene Symbol: KLKB1
2 Cross references
206 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSUAMG00000018620
Gene Symbol: KEAP1
2 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSUAMG00000018150
Gene Symbol: KDR
2 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSUAMG00000020469
Gene Symbol: KIF11
2 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).